Open access
Sep 2026
Host immune biomarkers associated with infection risk after CAR T-cell therapy.
BACKGROUND Infection is the leading cause of non-relapse mortality after CAR-T therapy, yet individual risk prediction remains challenging. This exploratory study evaluated immune correlates of infection and other treatment-emergent adverse events in patients with diffuse large B-cell lymphoma (DLBCL) receiving CAR-T....
Gemma K. Reynolds, Lewis J. Williams, Göknur Giner et al.
· Journal of Infection · 0 citations